1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow GIST: new trials by email Literature Review of GIST trials Research Report on GIST
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Olverembatinib in SDH-deficient GIST. Olverembatinib - GIST | Phase 3 | Recruiting | Ascentage Pharma Group Inc. | 40 | 2024-11-11 | 2026-07-23 |
| A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib Ripretinib, Sunitinib - GIST | Phase 3 | Active not recruiting | Deciphera Pharmaceuticals, LLC | 54 | 2023-12-13 | 2025-12-17 |
| NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours Intraoperative near-infrared fluorescence imaging using indocyaninegreen - GIST | Phase 2 / Phase 3 | Unknown | Leiden University Medical Center | 10 | 2020-06-17 | 2021-02-18 |
| (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST avapritinib, regorafenib - GIST | Phase 3 | Completed | Blueprint Medicines Corporation | 476 | 2018-03-26 | 2022-10-06 |
Gastrointestinal Stromal Tumors (2)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2)
Sunitinib (1) · avapritinib (1) · olverembatinib (1) · regorafenib (1) · ripretinib (1)
Ascentage Pharma Group Inc. (1) · Blueprint Medicines Corporation (1) · Deciphera Pharmaceuticals, LLC (1) · Leiden University Medical Center (1)
Netherlands (3) · Australia (2) · Canada (2) · China (2) · France (2) · Germany (2) · Italy (2) · Poland (2) · South Korea (2) · Spain (2) · United Kingdom (2) · United States (2) · Austria (1) · Belgium (1) · Brazil (1)